Check-Cap Ltd Cash Flow Conversion Efficiency

Latest as of December 2023: -0.149x

Check-Cap Ltd cash flow conversion efficiency. Based on the latest financial reports, Check-Cap Ltd (7CC) has a cash flow conversion efficiency ratio of -0.149x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.54 Million ≈ $-4.14 Million USD) by net assets (€23.69 Million ≈ $27.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Check-Cap Ltd (2016–2025)

Cash flow conversion efficiency of Check-Cap Ltd from 2016 to 2025. This chart illustrates how Check-Cap Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Check-Cap Ltd stock price for real-time trading data and today's change.

Check-Cap Ltd Cash Flow Conversion Ratio Explained

Check-Cap Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Check-Cap Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Check-Cap Ltd ranked by their cash flow conversion efficiency. Also see 7CC company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Top Shelf International Holdings Ltd
AU:TSI
-0.324x
Ostasiatiske Kompagni A/S
CO:OKEAC
0.523x
Kinovo PLC
LSE:KINO
-0.845x
Celsius Resources Ltd
AU:CLA
-0.087x
Polygiene AB
ST:POLYG
0.000x
Phoenix Motor Inc. Common Stock
NASDAQ:PEV
-0.277x
GENOMTEC S.A. ZY -10
F:4VI
N/A
Avon Protection PLC
LSE:AVON
0.014x

Annual Cash Flow Conversion Efficiency for Check-Cap Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Check-Cap Ltd from 2016 to 2025. Review Check-Cap Ltd leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €3.44 Million
≈ $4.02 Million
€-46.00K
≈ $-53.78K
-0.013x -100.24%
2024-12-31 €-1.45 Million
≈ $-1.70 Million
€-8.00 Million
≈ $-9.36 Million
5.520x +871.22%
2023-12-31 €23.69 Million
≈ $27.69 Million
€-16.95 Million
≈ $-19.82 Million
-0.716x -58.06%
2022-12-31 €41.31 Million
≈ $48.30 Million
€-18.71 Million
≈ $-21.87 Million
-0.453x -41.13%
2021-12-31 €50.69 Million
≈ $59.26 Million
€-16.26 Million
≈ $-19.01 Million
-0.321x +59.93%
2020-12-31 €16.38 Million
≈ $19.15 Million
€-13.11 Million
≈ $-15.33 Million
-0.801x +61.14%
2019-12-31 €6.23 Million
≈ $7.29 Million
€-12.84 Million
≈ $-15.01 Million
-2.060x -165.41%
2018-12-31 €13.03 Million
≈ $15.23 Million
€-10.11 Million
≈ $-11.82 Million
-0.776x +48.99%
2017-12-31 €5.91 Million
≈ $6.90 Million
€-8.99 Million
≈ $-10.51 Million
-1.522x -99.89%
2016-12-31 €10.41 Million
≈ $12.17 Million
€-7.92 Million
≈ $-9.26 Million
-0.761x --

About Check-Cap Ltd

F:7CC Germany Diagnostics & Research
Market Cap
$14.19 Million
€12.14 Million EUR
Market Cap Rank
#27158 Global
#2321 in Germany
Share Price
€1.57
Change (1 day)
-9.25%
52-Week Range
€0.82 - €7.80
All Time High
€736.32
About

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.